FDA Greenlights BridgeBio's Submission for a Groundbreaking Treatment for Limb-Girdle Muscular Dystrophy

FDA Greenlights BridgeBio’s Submission for a Groundbreaking Treatment for Limb-Girdle Muscular Dystrophy